Management of Severe Developmental Regression in an Autistic Child with a 1q21.3 Microdeletion and Self-Injurious

Cora Cravero1, Vincent Guinchat1, Jean Xavier1

  • 1Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, 47-83 Bd de l'Hôpital, 75013 Paris, France.

Insights

A rare 1q21.3 microdeletion in a nonverbal autistic boy with intellectual disability led to severe self-injurious behaviors and developmental regression. Multidisciplinary inpatient care, pain management, and tailored therapies significantly reduced self-harm and improved development.

Area of Science:

  • Neurodevelopmental disorders
  • Genetics
  • Behavioral science

Background:

  • Autism spectrum disorder (ASD) and intellectual disability (ID) can present with complex behavioral challenges.
  • Rare genetic microdeletions, such as 1q21.3, are increasingly recognized as contributing factors to neurodevelopmental phenotypes.
  • Self-injurious behaviors (SIB) in individuals with severe developmental disabilities pose significant clinical challenges and can lead to secondary complications like blindness.

Observation:

  • A young boy with nonverbal autism and intellectual disability was diagnosed with a de novo 1q21.3 microdeletion.
  • The patient exhibited early-onset, extreme self-injurious behaviors resulting in blindness and severe developmental regression.
  • Conventional interventions were insufficient to manage the severity of the SIB and regression.

Findings:

  • A multidisciplinary neurodevelopmental inpatient approach led to a significant reduction in self-injurious behaviors.
  • Addressing underlying somatic pain through opiate blockers and mood stabilization was crucial for behavioral improvement.
  • Sensorimotor developmental approaches, including therapeutic body wraps, and blindness-adapted psychoeducation facilitated communication gains.

Implications:

  • This case highlights the complex interplay between genetic factors, severe behavioral phenotypes, and neurodevelopmental trajectories.
  • Multidisciplinary, inpatient management targeting somatic pain, mood, and sensory-motor needs can effectively mitigate severe SIB and developmental regression in rare genetic disorders.
  • Tailored therapeutic strategies, including adapted communication methods, are essential for improving quality of life in individuals with complex neurodevelopmental profiles and acquired disabilities.

Related Concept Videos